The study, done on a mild-mannered relative of the virus that causes COVID-19, paves the way for seeing more clearly how spike proteins initiate infections, with an eye to preventing and treating them.

The lab’s X-ray laser recently joined other facilities in making remote science possible from any corner of the world, a trend that will likely continue into the future.

The results of a new scientific study reveal how photosynthetic reaction centers adapt to make light-driven reactions more efficient.

A better understanding of how this happens could help researchers hone future electronic measurements and offer insights into how X-rays interact with matter on ultrafast time scales.

The center complements other NIH centers at SLAC and elsewhere that broaden access to this cutting-edge technology for biomedical research.

Images reveal how some antibodies may block SARS-CoV-2 infection.

Scientists at the Stanford Synchrotron Radiation Lightsource will study plastics and biologically-motivated processes that break them down in hopes of finding more efficient ways to “upcycle” them.

FACET-II will pave the way for a future generation of particle colliders and powerful light sources, opening avenues in high-energy physics, medicine, and materials, biological and energy science.

No human cell can function without these tiny machines, which cause disease when they go haywire and offer potential targets for therapeutic drugs.

They found that gently heating N95 masks in high relative humidity could inactivate SARS-CoV-2 virus trapped within the masks, without degrading the masks’ performance.

Using SLAC’s synchrotron, Summers improves fundamental knowledge of the role of copper in the brain and investigates treatments for Alzheimer’s disease.

University of Alberta researchers worked with SLAC X-ray scientists to explore the potential of a feline coronavirus drug that may be effective against SARS-CoV-2.